Clinical Trial Update: A Reversal in the Vascularity of Metastatic Liver Tumors From Colorectal Cancer After the Cessation of Anti-VEGF Therapy

View source ↗

Summary

A completed clinical trial observed changes in vascularity of metastatic liver tumors from colorectal cancer after stopping anti-VEGF therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Snippet

Sponsor: NHO - Matsumoto Medical Center | Conditions: Colorectal Cancer | Status: COMPLETED